Summary

Summary Novartis is a leading global healthcare company headquartered in Switzerland, committed to reimagining medicine to improve and extend people’s lives. We leverage innovative science and digital technologies to deliver transformative treatments in areas of significant medical need. Consistently ranked among the world’s top investors in research and development, we strive to discover and develop breakthrough medicines that make a real difference for patients worldwide.

The Strategy & Growth (S&G) Business Unit, established in 2022, serves as the enterprise decision-support function. Our mission is to enable strategic decisions through objective data and analysis. We focus on:

Developing robust strategies for core therapeutic areas to provide a unified enterprise-wide view. Delivering timely, actionable internal and external insights to sharpen and enhance strategic direction. Standardising portfolio prioritisation and analytics to inform decisions objectively, maintain product leadership, and maximise innovation. Identifying external opportunities to accelerate pipeline growth with high-value, transformative medicines.